Clinical Evidence
Publications
Peer-reviewed data and conference results on ctDNA-based MRD detection in lymphoma and solid tumors.
Peer-Reviewed Data
Published evidence for LymphoVista and CancerVista
Five peer-reviewed publications and conference presentations document the analytical performance and clinical utility of our ctDNA assays. Each citation links to the original source.
Journal Articles
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA
Download PDF : CNS lymphoma outcome predictionIn-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detection
Download PDF : Genomic landscape and residual disease detection in Hodgkin's lymphomaConference Abstracts
LymphoVista HL - a Validated Assay for Genotyping and MRD Assessment in Hodgkin Lymphoma
Download PDF : LymphoVista HL assaySerial ctDNA monitoring in relapsed/refractory large B-cell lymphoma
Download PDF : Serial ctDNA monitoring in relapsed/refractory large B-cell lymphoma
For Clinical Partners
Precise Evidence. Confident Decisions.
Our clinical team answers questions on study design, endpoints, and how these data apply to your patients.
Talk to our clinical team →